EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Tetrazoles and Related Heterocycles as Promising Synthetic Antidiabetic Agents

Rostislav E Trifonov, Vladimir A Ostrovskii iD

International Journal of Molecular Sciences · 06.12.2023 · 24 (24) · 17190

DOI: 10.3390/ijms242417190 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.12.2023. Verfasst von Rostislav E Trifonov und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Technology of Nitrogen-Containing Organic Compounds, Saint Petersburg State Institute of Technology (Technical University…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Sodium-Glucose Transporter 2 Inhibitors, Dipeptidyl-Peptidase IV Inhibitors. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tetrazole heterocycle is a promising scaffold in drug design, and it is incorporated into active pharmaceutical ingredients of medications of various actions: hypotensives, diuretics, antihistamines, antibiotics, analgesics, and others. This heterocyclic system is metabolically stable and easily participates in various intermolecular interactions with different biological targets through hydrogen bonding, conjugation, or van der Waals forces. In the present review, a systematic analysis of the activity of tetrazole derivatives against type 2 diabetes mellitus (T2DM) has been performed. As it was shown, the tetrazolyl moiety is a key fragment of many antidiabetic agents with different activities, including the following: peroxisome proliferator-activated receptors (PPARs) agonists, protein tyrosine phosphatase 1B (PTP1B) inhibitors, aldose reductase (AR) inhibitors, dipeptidyl peptidase-4 (DPP-4) inhibitors and glucagon-like peptide 1 (GLP-1) agonists, G protein-coupled receptor (GPCRs) agonists, glycogen phosphorylases (GP) Inhibitors, α-glycosidase (AG) Inhibitors, sodium glucose co-transporter (SGLT) inhibitors, fructose-1,6-bisphosphatase (FBPase) inhibitors, IkB kinase ε (IKKε) and TANK binding kinase 1 (TBK1) inhibitors, and 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1). In many cases, the tetrazole-containing leader compounds markedly exceed the activity of medications already known and used in T2DM therapy, and some of them are undergoing clinical trials. In addition, tetrazole derivatives are very often used to act on diabetes-related targets or to treat post-diabetic disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Sodium-Glucose Transporter 2 InhibitorsDipeptidyl-Peptidase IV InhibitorsHumansHypoglycemic AgentsTetrazolesGlucagon-Like Peptide-1 Receptor Agonists

Stichwörter der Autor:innen

G protein-coupled receptor (GPCRs) agonistsaldose reductase (AR) inhibitorsantidiabetic agentsdipeptidyl peptidase-4 (DPP-4) inhibitorsperoxisome proliferator-activated receptors (PPARs) agoniststetrazolestype 2 diabetes mellitus

Substanzen

Hypoglycemic AgentsSodium-Glucose Transporter 2 InhibitorsDipeptidyl-Peptidase IV InhibitorsTetrazolesGlucagon-Like Peptide-1 Receptor Agonists

Autor:innen und Institutionen

  • Department of Chemistry and Technology of Nitrogen-Containing Organic Compounds, Saint Petersburg State Institute of Technology (Technical University), St. Petersburg 190013, Russia.
  • Saint Petersburg Federal Research Center of the Russian Academy of Sciences (SPC RAS), St. Petersburg 199178, Russia.

ORCID-Profile: Vladimir A Ostrovskii

Förderung

  • Russian Science Foundation

Zitieren

APA

Trifonov, R. E., & Ostrovskii, V. A. (2023). Tetrazoles and Related Heterocycles as Promising Synthetic Antidiabetic Agents. International Journal of Molecular Sciences, 24(24), 17190. https://doi.org/10.3390/ijms242417190

Vancouver

Trifonov RE, Ostrovskii VA. Tetrazoles and Related Heterocycles as Promising Synthetic Antidiabetic Agents. International Journal of Molecular Sciences. 2023;24(24):17190. doi:10.3390/ijms242417190

BibTeX
@article{Trifonov2023,
  author = {Trifonov, Rostislav E and Ostrovskii, Vladimir A},
  title = {Tetrazoles and Related Heterocycles as Promising Synthetic Antidiabetic Agents},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {24},
  pages = {17190},
  doi = {10.3390/ijms242417190}
}
Kostenlos starten →